I-123 iofetamine single-photon computed emission tomography in rapid cycling bipolar disorder: a clinical study. (Q51106791)

29 March 2018

title

I-123 iofetamine single-photon computed emission tomography in rapid cycling bipolar disorder: a clinical study. (English)

1 reference

29 March 2018

1 reference

Gyulai L

1

1 reference

29 March 2018

Alavi A

2

1 reference

29 March 2018

Broich K

3

1 reference

29 March 2018

Reilley J

4

1 reference

29 March 2018

Ball WB

5

1 reference

29 March 2018

Whybrow PC

6

1 reference

29 March 2018

language of work or name

English

0 references

publication date

1 January 1997

1 reference

29 March 2018

published in

Biological Psychiatry

1 reference

29 March 2018

volume

41

1 reference

29 March 2018

issue

2

1 reference

29 March 2018

page(s)

152-161

1 reference

29 March 2018

Temporal lobe asymmetry with iofetamine (IMP) SPECT imaging in patients with major depression

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900002-9

Carbamazepine in manic-depressive illness: a new treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900002-9

Rapid cycling bipolar affective disorder. I. Association with grade I hypothyroidism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900002-9

Cerebral metabolic rates for glucose in mood disorders. Studies with positron emission tomography and fluorodeoxyglucose F 18.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900002-9

Reduction of prefrontal cortex glucose metabolism common to three types of depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900002-9

Efficacy of divalproex vs lithium and placebo in the treatment of mania. The Depakote Mania Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900002-9

Cerebral hyperemia in electrically induced epileptic seizures.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900002-9

Anteroposterior gradients in cerebral glucose use in schizophrenia and affective disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900002-9

Frontal cortex and basal ganglia metabolic rates assessed by positron emission tomography with [18F]2-deoxyglucose in affective illness.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900002-9

Spectrum of efficacy of valproate in 55 patients with rapid-cycling bipolar disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900002-9

Neurobehavioral aspects of affective disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900002-9

Regional cerebral blood flow abnormalities in depressed patients with cognitive impairment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900002-9

Clinical Factors in Lithium Carbonate Prophylaxis Failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900002-9

Rapid cycling manic depressive patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900002-9

Psychosis and temporal lobe epilepsy. A controlled investigation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900002-9

State changes in brain activity shown by the uptake of 99mTc-exametazime with single photon emission tomography in major depression before and after treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900002-9

A rating scale for depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900002-9

PRELIMINARY ANALYSIS OF FUNCTIONS OF THE TEMPORAL LOBES IN MONKEYS

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900002-9

Current and future radiopharmaceuticals for brain imaging with single photon emission computed tomography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900002-9

HIPDM single photon emission computed tomography brain imaging in partial onset secondarily generalized tonic-clonic seizures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900002-9

Left prefrontal glucose hypometabolism in the depressed state: a confirmation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900002-9

SPECT findings in patients with primary mania.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900002-9

Single photon emission computed tomography (SPECT) with [123I]IMP in the differential diagnosis of psychiatric disorders.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900002-9

Single-photon emission computed tomography of the brain in acute mania and schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900002-9

Comparison of the antimanic efficacy of carbamazepine and chlorpromazine: A double-blind controlled study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900002-9

A PROPOSED MECHANISM OF EMOTION

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900002-9

Quantification of regional cerebral blood flow with IMP-SPECT. Reproducibility and clinical relevance of flow values

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900002-9

Conditioning and sensitisation in the longitudinal course of affective illness

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900002-9

Glucose utilization in the temporal cortex of affectively ill patients: positron emission tomography.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900002-9

Control mechanisms in cortical epileptogenic foci. "Surround" inhibition.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900002-9

Comparison of mania and depression after brain injury: causal factors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900002-9

Localization of epileptic foci with postictal single photon emission computed tomography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900002-9

Mania after brain injury. A controlled study of causative factors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900002-9

Manic-depressive and pure manic states after brain lesions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900002-9

Regional cerebral blood flow in depression and mania

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900002-9

Rapid cycling affective disorder: contributing factors and treatment responses in 51 patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900002-9

A rating scale for mania: reliability, validity and sensitivity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900002-9

10.1016/S0006-3223(96)00002-9

7 January 2021

Identifiers

DOI

1 reference

29 March 2018

PubMed ID

9018385

1 reference

29 March 2018